<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="editorial"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id><journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id><journal-id journal-id-type="publisher-id">jbpneu</journal-id><journal-title-group><journal-title>Jornal Brasileiro de Pneumologia</journal-title></journal-title-group><issn pub-type="ppub">1806-3713</issn><issn pub-type="epub">1806-3756</issn><publisher><publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">35830057</article-id><article-id pub-id-type="pmc">PMC9262428</article-id><article-id pub-id-type="doi">10.36416/1806-3756/e20220187</article-id><article-id pub-id-type="other">00000</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Challenges in the management of patients with pulmonary embolism in Brazil</article-title><trans-title-group xml:lang="pt"><trans-title>Desafios assistenciais aos pacientes com tromboembolismo pulmonar no Brasil</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4253-4935</contrib-id><name><surname>Amado</surname><given-names>Veronica Moreira</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4511-9123</contrib-id><name><surname>Santana</surname><given-names>Alfredo Nicodemos Cruz</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>. Universidade de Bras&#x000ed;lia, Faculdade de Medicina, Campus Darcy Ribeiro, Bras&#x000ed;lia (DF) Brasil.</aff><aff id="aff2">
<label>2</label>. Curso de Medicina e Enfermagem, Escola Superior de Ci&#x000ea;ncias da Sa&#x000fa;de, Hospital Regional da Asa Norte - HRAN - Bras&#x000ed;lia (DF) Brasil.</aff><aff id="aff3">
<label>3</label>. N&#x000fa;cleo Avan&#x000e7;ado de T&#x000f3;rax, Hospital S&#x000ed;rio-Liban&#x000ea;s, Bras&#x000ed;lia (DF) Brasil.</aff><author-notes><fn fn-type="con" id="fn01"><p><bold>AUTHOR CONTRIBUTIONS:</bold> Both authors contributed equally to the conceptualization and critical analysis of the manuscript, having written, reviewed, revised, and approved it for submission. </p></fn><fn fn-type="COI-statement" id="fn02"><p><bold>CONFLICTS OF INTEREST:</bold> None declared. </p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>7</month><year>2022</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2022</year></pub-date><volume>48</volume><issue>3</issue><elocation-id>e20220187</elocation-id><permissions><copyright-statement>&#x000a9; 2022 Sociedade Brasileira de Pneumologia e Tisiologia</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Sociedade Brasileira de Pneumologia e Tisiologia</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited.</license-p></license></permissions><counts><fig-count count="0"/><table-count count="0"/><equation-count count="0"/><ref-count count="10"/></counts></article-meta></front><body><p>Pulmonary thromboembolism (PTE) is a disease that has a high annual incidence (29-78 new cases per 100,000 person-years),<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref> having ranked third among the leading causes of cardiovascular death in the last three decades.<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref> Therefore, it is important to understand the economic impact of PTE and the factors involved in its prognosis. In the current issue of the <italic>Jornal Brasileiro de Pneumologia</italic> (JBP), an epidemiological study shows relevant data on the number of hospitalizations for PTE, costs of PTE treatment, and mortality of PTE in the five regions of Brazil.<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
</p><p>The risk of PTE increases with age, as does the risk of common aging-related comorbidities such as cardiovascular disease, chronic lung disease, and cancer.<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref> Aging and age-related comorbidities contribute to increased length of hospital stay, costs, and risk of morbidity and mortality from thromboembolic events.<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref> Given the increase in life expectancy in recent decades, with the aging rate in Brazil having increased by 268% from 1970 to 2010, particularly in the southern and southeastern regions of the country,<xref rid="B6" ref-type="bibr">
<sup>6</sup>
</xref> the number of hospital admissions for PTE has increased: the mean number of hospitalizations was 2.57/100,000 population in 2008 and 4.44/100,000 population in 2019.<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
</p><p>In countries in which there are major differences across regions, including high social inequality, widespread poverty, and limited access to health care, it can be assumed that delayed care results in poorer clinical status. These factors, together with inappropriate or inadequate home care after discharge, can lead to increased hospital stays, increased costs, and worse prognosis.<xref rid="B7" ref-type="bibr">
<sup>7</sup>
</xref> In recent years, new technologies have been developed for the diagnosis and treatment of PTE, contributing to an increase in hospital costs in Brazil and worldwide.<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref> Although these new technologies can have a positive impact on patient management, they entail an increase in health care costs.<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>
</p><p>For decades, initial anticoagulation therapy was performed in hospitals, even in cases in which the risk of morbidity and mortality was low, because of the need to transition from anticoagulation with unfractionated heparin or low-molecular-weight heparin to coumarins. In recent years, with the emergence of oral medications that dispense with this transition and the need for periodic control of the effect, shorter hospital stays and even initial home treatment have begun to be studied as alternatives to prolonged hospitalizations, although the safety of these strategies has yet to be confirmed.<xref rid="B8" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>-</sup>
<xref rid="B10" ref-type="bibr">
<sup>10</sup>
</xref> In addition, these therapeutic alternatives have yet to be incorporated into the Brazilian Unified Health Care System at the national level. Furthermore, logistical difficulties in gaining access to health care facilities constitute a barrier to early hospital discharge in socioeconomically disadvantaged populations.<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
</p><p>In Brazil, hospital stays for PTE are still long, having remained practically unchanged in recent years. In 2008, the mean length of stay was 9.1 days; in 2019, it was 8.7 days. However, there was a trend toward a reduction in in-hospital mortality (which was 21.21% in 2008 and 17.1% in 2019). Nevertheless, this reduction was more pronounced in the southern and southeastern regions of the country; in-hospital mortality remained highest in northeastern Brazil (25.1%), evidencing the impact that socioeconomic inequalities have on the delivery of health care in Brazil.<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>
</p><p>Epidemiological studies, such as the one published in this issue of the JBP,<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref> provide a better understanding of the problems related to the delivery of health care, as well as informing public policies to improve the quality and cost-effectiveness of health care. </p></body><back><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heit</surname><given-names>JA</given-names></name>
</person-group><article-title>Epidemiology of venous thromboembolism</article-title><source>Nat Rev Cardiol</source><year>2015</year><volume>12</volume><issue>8</issue><fpage>464</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2015.83</pub-id><pub-id pub-id-type="pmid">26076949</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martin</surname><given-names>KA</given-names></name>
<name><surname>Molsberry</surname><given-names>R</given-names></name>
<name><surname>Cuttica</surname><given-names>MJ</given-names></name>
<name><surname>Desai</surname><given-names>KR</given-names></name>
<name><surname>Schimmel</surname><given-names>DR</given-names></name>
<name><surname>Khan</surname><given-names>SS</given-names></name>
</person-group><article-title>Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018</article-title><source>J Am Heart Assoc</source><year>2020</year><volume>9</volume><issue>17</issue><elocation-id>e016784</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.120.016784</pub-id><pub-id pub-id-type="pmid">32809909</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gomes</surname><given-names>JA</given-names></name>
<name><surname>Barros</surname><given-names>JEB</given-names></name>
<name><surname>Nascimento</surname><given-names>ALOD</given-names></name>
<name><surname>Rocha</surname><given-names>CAO</given-names></name>
<name><surname>Almeida</surname><given-names>JPO</given-names></name>
<name><surname>Santana</surname><given-names>GBA</given-names></name>
</person-group><article-title>Hospitalizations for pulmonary embolism in Brazil (2008-2019) an ecological and time series study</article-title><source>J Bras Pneumol</source><year>2022</year><volume>48</volume><issue>3</issue><elocation-id>e20210434</elocation-id><pub-id pub-id-type="pmid">35476042</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pauley</surname><given-names>E</given-names></name>
<name><surname>Orgel</surname><given-names>R</given-names></name>
<name><surname>Rossi</surname><given-names>JS</given-names></name>
<name><surname>Strassle</surname><given-names>PD</given-names></name>
</person-group><article-title>Age-Stratified National Trends in Pulmonary Embolism Admissions</article-title><source>Chest</source><year>2019</year><volume>156</volume><issue>4</issue><fpage>733</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1016/j.chest.2019.05.021</pub-id><pub-id pub-id-type="pmid">31233745</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carneiro</surname><given-names>RM</given-names></name>
<name><surname>van Bellen</surname><given-names>B</given-names></name>
<name><surname>Santana</surname><given-names>PRP</given-names></name>
<name><surname>Gomes</surname><given-names>ACP</given-names></name>
</person-group><article-title>Preval&#x000ea;ncia de tromboembolismo pulmonar incidental em pacientes oncol&#x000f3;gicos an&#x000e1;lise retrospectiva em grande centro</article-title><source>J Vasc Bras</source><year>2017</year><volume>16</volume><issue>3</issue><fpage>232</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1590/1677-5449.002117</pub-id><pub-id pub-id-type="pmid">29930652</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Closs</surname><given-names>VE</given-names></name>
<name><surname>Schwanke</surname><given-names>CHA</given-names></name>
</person-group><article-title>Aging index development in Brazil, regions, and federative units from 1970 to 2010</article-title><source>Rev Bras Geriatr Gerontol</source><year>2010</year><volume>15</volume><issue>3</issue><fpage>443</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1590/S1809-98232012000300006</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andrade</surname><given-names>MV</given-names></name>
<name><surname>Noronha</surname><given-names>KVMS</given-names></name>
<name><surname>Menezes</surname><given-names>RM</given-names></name>
<name><surname>Souza</surname><given-names>MN</given-names></name>
<name><surname>Reis</surname><given-names>CB</given-names></name>
<name><surname>Martins</surname><given-names>DR</given-names></name>
</person-group><article-title>Desigualdade socioecon&#x000f4;mica no acesso aos servi&#x000e7;os de sa&#x000fa;de no Brasil Um estudo comparativo entre as regi&#x000f5;es brasileiras em 1998 e 2008</article-title><source>Econ Apl</source><year>2013</year><volume>17</volume><issue>4</issue><fpage>623</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1590/S1413-80502013000400005</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fernandes</surname><given-names>CJ</given-names></name>
<name><surname>Alves</surname><given-names>JL</given-names><suffix>J&#x000fa;nior</suffix></name>
<name><surname>Gavilanes</surname><given-names>F</given-names></name>
<name><surname>Prada</surname><given-names>LF</given-names></name>
<name><surname>Morinaga</surname><given-names>LK</given-names></name>
<name><surname>Souza</surname><given-names>R</given-names></name>
</person-group><article-title>New anticoagulants for the treatment of venous thromboembolism</article-title><source>J Bras Pneumol</source><year>2016</year><volume>42</volume><issue>2</issue><fpage>146</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1590/S1806-37562016042020068</pub-id><pub-id pub-id-type="pmid">27167437</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yoo</surname><given-names>HH</given-names></name>
<name><surname>Nunes-Nogueira</surname><given-names>VS</given-names></name>
<name><surname>Fortes Villas Boas</surname><given-names>PJ</given-names></name>
<name><surname>Broderick</surname><given-names>C</given-names></name>
</person-group><article-title>Outpatient versus inpatient treatment for acute pulmonary embolism</article-title><source>Cochrane Database Syst Rev</source><year>2019</year><volume>3</volume><issue>3</issue><fpage>CD010019</fpage><lpage>CD010019</lpage><pub-id pub-id-type="doi">10.1002/14651858.CD010019.pub3</pub-id><pub-id pub-id-type="pmid">30839095</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kohn</surname><given-names>CG</given-names></name>
<name><surname>Fermann</surname><given-names>GJ</given-names></name>
<name><surname>Peacock</surname><given-names>WF</given-names></name>
<name><surname>Wells</surname><given-names>PS</given-names></name>
<name><surname>Baugh</surname><given-names>CW</given-names></name>
<name><surname>Ashton</surname><given-names>V</given-names></name>
</person-group><article-title>Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism a systematic review of real-world studies</article-title><source>Curr Med Res Opin</source><year>2017</year><volume>33</volume><issue>9</issue><fpage>1697</fpage><lpage>1703</lpage><pub-id pub-id-type="doi">10.1080/03007995.2017.1349659</pub-id><pub-id pub-id-type="pmid">28665208</pub-id></element-citation></ref></ref-list></back></article>
